TGA
STJ

Trilogy Global Advisors’s St Jude Medical STJ Stock Holding History

Trilogy Global Advisors’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-367,529
Closed -$25.5M – 90
2014
Q2 		$25.5M Buy
367,529
+1,503
+0.4% +$97.4K 0.49% 61
2014
Q1 		$23.9M Sell
366,026
-459,374
-56% -$29.9M 0.48% 66
2013
Q4 		$51.1M Sell
825,400
-556,873
-40% -$32.2M 1.04% 42
2013
Q3 		$74.1M Buy
1,382,273
+47,657
+4% +$2.45M 1.6% 25
2013
Q2 		$60.9M Buy
+1,334,616
New +$57.8M 1.41% 31

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Trilogy Global Advisors's STJ Position: Q3 2014 in Review

Trilogy Global Advisors sold out of St Jude Medical (STJ) in Q3 2014, closing a stake of 367,529 shares — an estimated $25.5M sold.

Trilogy Global Advisors first reported a position in STJ in Q2 2013 and held it in 5 quarters. The position peaked at $74.1M in Q3 2013. 563 funds tracked by Wall St. Rank hold STJ as of Q3 2014.

  • Trilogy Global Advisors reported no remaining St Jude Medical position as of Q3 2014 after selling out during the quarter.
  • Trilogy Global Advisors sold 367,529 St Jude Medical shares in Q3 2014, an estimated $25.5M.
  • Trilogy Global Advisors first reported a position in St Jude Medical in Q2 2013 and held it in 5 quarters.
  • Trilogy Global Advisors's St Jude Medical position peaked at $74.1M in Q3 2013.
  • 563 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2014.

Based on Trilogy Global Advisors's 13F filing for Q3 2014, filed 12 Nov 2014.